Loading...
Loading...
Among the 7 tracked institutional investors we monitor, HRTX (HERON THERAPEUTICS INC) is held with a combined value of $32.11M across 33,992,369 shares. The largest holder is VANGUARD GROUP INC with a position worth $12.77M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds increased their holdings. 4 funds reduced their position.
Total Institutional Value
$32.11M
Total Shares Held
33,992,369
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $12.77M | 0.00% | New |
| 2 | BlackRock, Inc. | $8.09M | 0.00% | -1.1% |
| 3 | MILLENNIUM MANAGEMENT LLC | $6.11M | 0.00% | +6.4% |
| 4 | STATE STREET CORP | $3.08M | 0.00% | +1.7% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $1.37M | 0.00% | -10.3% |
| 6 | CITADEL ADVISORS LLC | $651.98K | 0.00% | -61.8% |
| 7 | FMR LLC | $46.56K | 0.00% | -30.9% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of HRTX with a position worth $12.77M, representing 0.00% of their portfolio. In total, 7 institutional investors hold HRTX with a combined value of $32.11M.
In the most recent quarter, 1 fund opened a new position in HRTX. Additionally, 2 increased their holdings and 4 reduced their positions.
Institutional investors hold $32.11M worth of HRTX stock across 7 positions. The largest institutional holder is VANGUARD GROUP INC with $12.77M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For HRTX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their HRTX positions.